Reviewing Verisante Technology (VRSEF) & U.S. Physical Therapy (USPH)

Verisante Technology (OTCMKTS:VRSEF) and U.S. Physical Therapy (NYSE:USPH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Insider and Institutional Ownership

99.6% of U.S. Physical Therapy shares are held by institutional investors. 2.5% of U.S. Physical Therapy shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Risk and Volatility

Verisante Technology has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, U.S. Physical Therapy has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.

Dividends

U.S. Physical Therapy pays an annual dividend of $0.92 per share and has a dividend yield of 0.8%. Verisante Technology does not pay a dividend. U.S. Physical Therapy pays out 44.2% of its earnings in the form of a dividend. U.S. Physical Therapy has raised its dividend for 7 consecutive years.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Verisante Technology and U.S. Physical Therapy, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Verisante Technology 0 0 0 0 N/A
U.S. Physical Therapy 0 4 0 0 2.00

U.S. Physical Therapy has a consensus target price of $106.00, suggesting a potential downside of 5.04%. Given U.S. Physical Therapy’s higher probable upside, analysts plainly believe U.S. Physical Therapy is more favorable than Verisante Technology.

Earnings and Valuation

This table compares Verisante Technology and U.S. Physical Therapy’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Verisante Technology $20,000.00 0.49 -$1.21 million N/A N/A
U.S. Physical Therapy $414.05 million 3.42 $22.25 million $2.08 53.67

U.S. Physical Therapy has higher revenue and earnings than Verisante Technology.

Profitability

This table compares Verisante Technology and U.S. Physical Therapy’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Verisante Technology N/A N/A N/A
U.S. Physical Therapy 5.58% 17.64% 8.56%

Summary

U.S. Physical Therapy beats Verisante Technology on 11 of the 13 factors compared between the two stocks.

About Verisante Technology

Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

Receive News & Ratings for Verisante Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verisante Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply